{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:44:17Z","timestamp":1693943057131},"reference-count":20,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018,5,25]]},"DOI":"10.1253\/circj.cj-17-1114","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T22:20:15Z","timestamp":1523571615000},"page":"1552-1557","source":"Crossref","is-referenced-by-count":7,"title":["Periprocedural Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation Without Discontinuation of a Vitamin K Antagonist and Direct Oral Anticoagulants"],"prefix":"10.1253","volume":"82","author":[{"given":"Toshiya","family":"Kojima","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Fujiu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"Department of Ubiquitous Health Informatics, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Fukuma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaku","family":"Oguri","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"Clinical Research Support Center, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Hasumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. <i>Europace<\/i> 2012; 14: 528\u2013606.","DOI":"10.1093\/europace\/eus027"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: Results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. <i>Circulation<\/i> 2014; 129: 2638\u20132644.","DOI":"10.1161\/CIRCULATIONAHA.113.006426"},{"key":"3","unstructured":"3. Page SP, Siddiqui MS, Finlay M, Hunter RJ, Abrams DJ, Dhinoja M, et al. Catheter ablation for atrial fibrillation on uninterrupted warfarin: Can it be done without echo guidance? <i>J Cardiovasc Electrophysiol<\/i> 2011; 22: 265\u2013270."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. <i>N Engl J Med<\/i> 2017; 376: 1627\u20131636.","DOI":"10.1056\/NEJMoa1701005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lakkireddy D, Reddy YM, Di Biase L, Vallakati A, Mansour MC, Santangeli P, et al. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry. <i>J Am Coll Cardiol<\/i> 2014; 63: 982\u2013988.","DOI":"10.1016\/j.jacc.2013.11.039"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, et al. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation. <i>J Cardiovasc Electrophysiol<\/i> 2013; 24: 861\u2013865.","DOI":"10.1111\/jce.12143"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. <i>Heart Rhythm<\/i> 2017; 14: e275\u2013e444.","DOI":"10.1016\/j.hrthm.2017.05.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. <i>Europace<\/i> 2017; 20: 157\u2013208.","DOI":"10.1093\/europace\/eux275"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Briceno DF, Villablanca PA, Lupercio F, Kargoli F, Jagannath A, Londono A, et al. Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: Meta-analysis and meta-regression. <i>J Cardiovasc Electrophysiol<\/i> 2016; 27: 683\u2013693.","DOI":"10.1111\/jce.12975"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Di Biase L, Elayi CS, Fahmy TS, Martin DO, Ching CK, Barrett C, et al. Atrial fibrillation ablation strategies for paroxysmal patients: Randomized comparison between different techniques. <i>Circ Arrhythm Electrophysiol<\/i> 2009; 2: 113\u2013119.","DOI":"10.1161\/CIRCEP.108.798447"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. <i>Circulation<\/i> 2011; 123: 2736\u20132747.","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ, et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. <i>Circulation<\/i> 2012; 125: 1424\u20131431.","DOI":"10.1161\/CIRCULATIONAHA.111.060871"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shah RR, Pillai A, Schafer P, Meggo D, McElderry T, Plumb V, et al. Safety and efficacy of uninterrupted apixaban therapy versus warfarin during atrial fibrillation ablation. <i>Am J Cardiol<\/i> 2017; 120: 404\u2013407.","DOI":"10.1016\/j.amjcard.2017.04.041"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, et al. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation. <i>Intern Med<\/i> 2015; 54: 1167\u20131173.","DOI":"10.2169\/internalmedicine.54.3520"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, et al. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry. <i>J Am Coll Cardiol<\/i> 2012; 59: 1168\u20131174.","DOI":"10.1016\/j.jacc.2011.12.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kim JS, She F, Jongnarangsin K, Chugh A, Latchamsetty R, Ghanbari H, et al. Dabigatran vs. warfarin for radiofrequency catheter ablation of atrial fibrillation. <i>Heart Rhythm<\/i> 2013; 10: 483\u2013489.","DOI":"10.1016\/j.hrthm.2012.12.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, et al. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation. <i>Pacing Clin Electrophysiol<\/i> 2013; 36: 172\u2013179.","DOI":"10.1111\/pace.12036"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E, Cesarani F, et al. Radiofrequency catheter ablation of atrial fibrillation: A cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. <i>Circulation<\/i> 2010; 122: 1667\u20131673.","DOI":"10.1161\/CIRCULATIONAHA.110.937953"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. <i>Eur Heart J<\/i> 2016; 37: 2893\u20132962.","DOI":"10.1093\/eurheartj\/ehw210"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. <i>Europace<\/i> 2016; 18: 1609\u20131678.","DOI":"10.1093\/europace\/euw295"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/6\/82_CJ-17-1114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T07:49:17Z","timestamp":1660895357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/6\/82_CJ-17-1114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,25]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-1114","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,25]]}}}